$NERV SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G
20 Aug 2026	Form 3: Reilly Joseph H., Chief Operating Officer Holds 20,872 shares of Common Stock
20 Aug 2026	Form 3: Aliquo Anthony, Chief Accounting Officer Holds 1,683 shares of Common Stock
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
07 Aug 2026	10-Q
07 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	Form 4: Kaul Inderjit, Director Granted 12,147 Stock Option (right to buy)
08 Jul 2026	SCHEDULE 13G/A
05 Jun 2026	Form 4: Ahlholm Frederick W, SVP, CFO and Secretary Granted 680,000 Employee Stock Option (right to buy)
05 Jun 2026	Form 4: Luthringer Remy, Director Granted 1,690,700 Employee Stock Option (right to buy)
05 Jun 2026	Form 4: Laghrissi-Thode Fouzia, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Kupfer David, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Kaul Inderjit, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Van Heek G Jan, Director Granted 50,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Hasler Hans Peter, Director Granted 50,000 Stock Option (right to buy)
04 Jun 2026	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
27 May 2026	424B5
27 May 2026	8-K: Entry into a Material Definitive Agreement; Other Events

Comments